Biologic Evaluation of a Novel 188Re-Labeled Porphyrin in Mice Tumor Model
dc.contributor.author | Sarma, H. D. | |
dc.contributor.author | Das, T. | |
dc.contributor.author | Banerjee, S. | |
dc.contributor.author | Venkatesh, M. | |
dc.contributor.author | Vidyasagar, P. B. | |
dc.contributor.author | Mishra, K. P. | |
dc.date.accessioned | 2010-12-02T05:31:58Z | |
dc.date.available | 2010-12-02T05:31:58Z | |
dc.date.issued | 2010 | |
dc.format.extent | 4700 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Cancer Biotherapy and Radiopharmaceuticals. Vol. 25 (1): pp. 47-54 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/4048 | |
dc.language.iso | en | en |
dc.subject | 188Re | en |
dc.subject | porphyrin | en |
dc.subject | targeted radiotherapy | en |
dc.subject | tumor regression | en |
dc.subject | thymic lymphoma | en |
dc.subject | fibrosarcoma | en |
dc.title | Biologic Evaluation of a Novel 188Re-Labeled Porphyrin in Mice Tumor Model | en |
dc.type | Article | en |